A phase Ⅰstudy of the safety, tolerability, pharmacokinetics and phamacodynamics of single oral doses of yogliptin tablets in healthy Chinese volunteers
Latest Information Update: 23 Jan 2020
At a glance
- Drugs Yogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Easton Biopharmaceuticals
- 06 Jan 2017 New trial record